Clinical
Trials
Finder
Conditions
Locations
Institutions
Search Trials
Search
Conditions
Locations
Institutions
Search Trials
Institutions
Local Institution - 0322
Local Institution - 0322
Al Ain City, Abu Dhabi Emirate, United Arab Emirates
1 recruiting
Showing
1–1
of
1
trials
Recruiting
Phase 2
Phase 3
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
Breast Neoplasms
Bristol-Myers Squibb
500 enrolled
293 locations
NCT06926868
Feedback